Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic.
Roberta FuscoIgino SimonettiStefania IannielloAlberta VillanacciFrancesca GrassiFederica Dell'AversanaRoberta GrassiDiletta CozziEleonora BicciPierpaolo PalumboAlessandra BorgheresiAndrea GiovagnoniVittorio MieleAntonio BarileVincenza GranataPublished in: Journal of personalized medicine (2022)
Due to the increasing number of COVID-19-infected and vaccinated individuals, radiologists continue to see patients with COVID-19 pneumonitis and recall pneumonitis, which could result in additional workups and false-positive results. Moreover, cancer patients undergoing immunotherapy may show therapy-related pneumonitis during imaging management. This is otherwise known as immune checkpoint inhibitor-related pneumonitis. Following on from this background, radiologists should seek to know their patients' COVID-19 infection and vaccination history. Knowing the imaging features related to COVID-19 infection and vaccination is critical to avoiding misleading results and alarmism in patients and clinicians.
Keyphrases
- end stage renal disease
- patients undergoing
- ejection fraction
- chronic kidney disease
- newly diagnosed
- high resolution
- prognostic factors
- sars cov
- coronavirus disease
- interstitial lung disease
- squamous cell carcinoma
- pulmonary hypertension
- stem cells
- rheumatoid arthritis
- prostate cancer
- mesenchymal stem cells
- rectal cancer
- mass spectrometry
- drug induced
- replacement therapy